©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2011; 17(12): 1631-1641
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Table 4 Relative copy number of trefoil factor genes in cholangiocarcinoma
| No. | TFF1 | TFF2 | TFF3 |
| 1 | 2.031 | 1.691 | 2.311 |
| 2 | 1.431 | 1.371 | 1.721 |
| 3 | 1.551 | 1.371 | 2.341 |
| 4 | 2.001 | 2.191 | 2.911 |
| 5 | 1.461 | 1.731 | 1.841 |
| 6 | 1.791 | 1.781 | 3.211 |
| 7 | 1.821 | 2.741 | 3.671 |
| 8 | 1.441 | 0.96 | 1.381 |
| 9 | 1.551 | 0.98 | 1.781 |
| 10 | 1.551 | 0.99 | 1.561 |
| 11 | 1.681 | 1.30 | 2.361 |
| 12 | 1.681 | 1.10 | 1.401 |
| 13 | 1.971 | 0.85 | 2.171 |
| 14 | 1.611 | 1.33 | 2.321 |
| 15 | 1.581 | 1.00 | 1.581 |
| 16 | 1.621 | 1.22 | 2.891 |
| 17 | 1.491 | 1.17 | 1.351 |
| 18 | 1.521 | 0.97 | 2.251 |
| 19 | 1.621 | 1.21 | 1.851 |
| 20 | 1.14 | 1.10 | 1.551 |
| 21 | 1.17 | 0.98 | 1.661 |
| 22 | 0.83 | 0.92 | 1.571 |
| 23 | 1.14 | 1.03 | 1.481 |
| 24 | 0.98 | 1.14 | 1.411 |
| 25 | 1.06 | 1.15 | 1.651 |
| 26 | 1.06 | 1.33 | 2.131 |
| 27 | 1.32 | 0.91 | 1.421 |
| 28 | 1.20 | 1.01 | 1.571 |
| 29 | 1.27 | 1.631 | 1.851 |
| 30 | 1.32 | 1.891 | 1.581 |
| 31 | 1.29 | 2.681 | 2.161 |
| 32 | 1.28 | 1.381 | 1.871 |
| 33 | 0.88 | 1.481 | 1.631 |
| 34 | 1.491 | 1.421 | 1.24 |
| 35 | 1.381 | 0.71 | 0.99 |
| 36 | 1.771 | 1.03 | 1.12 |
| 37 | 1.381 | 0.92 | 1.29 |
| 38 | 1.511 | 1.17 | 0.94 |
| 39 | 1.521 | 1.02 | 1.23 |
| 40 | 1.461 | 1.12 | 1.34 |
| 41 | 1.421 | 0.97 | 1.34 |
| 42 | 1.371 | 0.73 | 0.79 |
| 43 | 0.84 | 0.472 | 0.58 |
| 44 | 0.63 | 0.372 | 0.88 |
| 45 | 0.68 | 0.532 | 0.86 |
| 46 | 0.63 | 0.512 | 0.83 |
| 47 | 0.86 | 0.382 | 0.55 |
| 48 | 0.76 | 0.422 | 0.462 |
| 49 | 0.92 | 0.68 | 0.452 |
| 50 | 0.82 | 0.85 | 0.512 |
| 51 | 1.07 | 0.79 | 0.97 |
| 52 | 1.15 | 0.59 | 1.11 |
| 53 | 0.95 | 0.84 | 1.02 |
| 54 | 0.84 | 0.79 | 0.68 |
| 55 | 0.74 | 0.77 | 1.26 |
| 56 | 0.77 | 1.03 | 0.83 |
| 57 | 1.13 | 1.31 | 1.26 |
| 58 | 1.13 | 1.03 | 1.20 |
| 59 | 1.00 | 0.88 | 0.89 |
| 60 | 1.17 | 0.70 | 1.15 |
| 61 | 0.94 | 0.91 | 1.19 |
| 62 | 0.76 | 0.72 | 0.63 |
| 63 | 1.15 | 1.04 | 1.15 |
| 64 | 1.25 | 0.95 | 0.87 |
| 65 | 1.01 | 0.77 | 0.90 |
| 66 | 1.11 | 1.27 | 1.03 |
| 67 | 0.85 | 0.62 | 0.54 |
| 68 | 1.10 | 0.96 | 1.23 |
| 69 | 1.06 | 0.92 | 0.84 |
| 70 | 1.05 | 0.88 | 0.80 |
| 71 | 1.12 | 1.09 | 1.10 |
| 72 | 1.33 | 0.87 | 1.22 |
| 73 | 0.87 | 1.01 | 0.71 |
| 74 | 0.75 | 0.88 | 0.76 |
| 75 | 1.04 | 0.74 | 1.14 |
| 76 | 1.10 | 0.67 | 0.93 |
| 77 | 1.06 | 0.98 | 1.14 |
| 78 | 1.10 | 0.97 | 1.30 |
| 79 | 1.22 | 0.87 | 1.21 |
| 80 | 1.16 | 0.95 | 1.32 |
| 81 | 1.13 | 1.07 | 1.32 |
| 82 | 1.10 | 0.88 | 1.24 |
| 83 | 0.92 | 1.05 | 1.31 |
| 84 | 1.14 | 0.97 | 1.09 |
| 85 | 1.01 | 0.98 | 1.14 |
| 86 | 1.13 | 1.07 | 1.26 |
| 87 | 0.91 | 0.59 | 1.23 |
| 88 | 0.97 | 0.69 | 1.16 |
| 89 | 0.91 | 0.78 | 0.91 |
| 90 | 1.06 | 0.71 | 1.06 |
| 91 | 1.15 | 0.69 | 0.88 |
| 92 | 0.96 | 0.58 | 0.57 |
| 93 | 1.03 | 1.00 | 1.30 |
| 94 | 1.20 | 0.93 | 1.06 |
| 95 | 1.25 | 0.76 | 0.77 |
| 96 | 1.28 | 1.21 | 1.24 |
| 97 | 1.28 | 1.15 | 0.94 |
| 98 | 1.10 | 0.82 | 0.99 |
| 99 | 1.28 | 0.73 | 0.71 |
| 100 | 0.87 | 0.59 | 0.91 |
| 101 | 1.05 | 0.78 | 1.28 |
| 102 | 1.00 | 0.70 | 0.99 |
| 103 | 0.66 | 0.61 | 0.61 |
| 104 | 0.89 | 0.74 | 0.80 |
| 105 | 0.88 | 0.57 | 0.60 |
| 106 | 0.82 | 0.56 | 0.58 |
| 107 | 1.04 | 1.05 | 1.04 |
| 108 | 0.90 | 0.98 | 0.88 |
| 109 | 0.65 | 0.65 | 0.64 |
| 110 | 1.18 | 1.21 | 1.20 |
- Citation: Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 2011; 17(12): 1631-1641
- URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1631